top of page
< Back

Cabergoline

卡麥角林

Mechanism of action:

Cabergoline 是一種多巴胺受體促效劑(long-acting dopamine D₂ receptor agonist),屬於麥角(ergot)的衍生物。Cabergoline 能活化腦下垂體 D₂ 受體,抑制腺苷酸環化酶(adenylate cyclase),減少 cAMP,降低催乳素的生產與釋放。此外,cabergoline 在黑質紋狀體通路(nigrostriatal pathway)能活化 D₂ 受體,增強多巴胺訊號,調節運動控制相關的神經迴路傳導。

​Reference(s):

1. Pastor P et al. (2003). Cabergoline in the treatment of Parkinson's disease. Neurologia. 


2. Curran MP et al. (2004). Cabergoline: a review of its use in the treatment of Parkinson's disease. Drugs.

bottom of page